Evidence map›Paper›PMID 36191185›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2022

Dissecting the stability determinants of a challenging de novo protein fold using massively parallel design and experimentation.

Tae-Eun Kim, Kotaro Tsuboyama, Scott Houliston, Cydney M Martell, Claire M Phoumyvong, Alexander Lemak, Hugh K Haddox, Cheryl H Arrowsmith, Gabriel J Rocklin

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 24 citations in OpenAlex.

  1. Applications and limitations of AI tools in enzyme design.Protein science : a publication of the Protein Society · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Global Analysis of Aggregation Determinants in Small Protein Domains.bioRxiv : the preprint server for biology · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Dissecting the stability determinants of a challenging de novo protein fold using massively parallel design and experimentation.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Tae-Eun KimDriskill Graduate Program in Life Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL 60611.ORCID 0000-0002-5583-1894
Kotaro TsuboyamaDepartment of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611.ORCID 0000-0002-9034-8179
Scott HoulistonStructural Genomics Consortium, University of Toronto, Toronto, ON M5G 1L7, Canada.ORCID 0000-0002-0113-0339
Cydney M MartellDriskill Graduate Program in Life Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL 60611.
Claire M PhoumyvongDriskill Graduate Program in Life Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL 60611.ORCID 0000-0003-1848-6523
Alexander LemakPrincess Margaret Cancer Centre, University of Toronto, Toronto, ON M5G 2M9, Canada.
Hugh K HaddoxDepartment of Biochemistry, University of Washington, Seattle, WA 98195.
Cheryl H ArrowsmithStructural Genomics Consortium, University of Toronto, Toronto, ON M5G 1L7, Canada.
Gabriel J RocklinDepartment of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611.
Northwestern University · USUniversity of Toronto · CAUniversity of Washington · US

Funding

Chemistry of Life Processes Predoctoral Training ProgramT32GM105538 · NIGMS · NORTHWESTERN UNIVERSITY · PI KELLEHER, NEIL L · 2013 to 2022
$2.7M
High-throughput discovery of protein energy landscapes in natural and designed proteomesDP2GM140927 · NIGMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Gabriel Jacob Rocklin · 2020 to 2026
$2.4M
HHS | NIH | National Institute of General Medical Sciences (NIGMS) 1DP2GM140927NIGMS NIH HHS DP2 GM140927NIGMS NIH HHS T32 GM105538
6 · The paper itself

Abstract

Designing entirely new protein structures remains challenging because we do not fully understand the biophysical determinants of folding stability. Yet, some protein folds are easier to design than others. Previous work identified the 43-residue ɑββɑ fold as especially challenging: The best designs had only a 2% success rate, compared to 39 to 87% success for other simple folds [G. J. Rocklin et al., Science 357, 168-175 (2017)]. This suggested the ɑββɑ fold would be a useful model system for gaining a deeper understanding of folding stability determinants and for testing new protein design methods. Here, we designed over 10,000 new ɑββɑ proteins and found over 3,000 of them to fold into stable structures using a high-throughput protease-based assay. NMR, hydrogen-deuterium exchange, circular dichroism, deep mutational scanning, and scrambled sequence control experiments indicated that our stable designs fold into their designed ɑββɑ structures with exceptional stability for their small size. Our large dataset enabled us to quantify the influence of universal stability determinants including nonpolar burial, helix capping, and buried unsatisfied polar atoms, as well as stability determinants unique to the ɑββɑ topology. Our work demonstrates how large-scale design and test cycles can solve challenging design problems while illuminating the biophysical determinants of folding.

Indexed as

Protein FoldingProteinsAmino Acid SequenceCircular DichroismDeuteriumPeptide HydrolasesProtein StabilityProtein Structure, SecondaryDeuteriumPeptide HydrolasesProteinsprotein designprotein engineeringprotein folding

Identifiers

PMID36191185
PMCPMC9564214
OpenAlexW4300594491

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.